University of Pittsburgh
400 Craig Hall
200 Forbes Pavilion
Pittsburgh
Pennsylvania
15260
United States
Tel: 412-624-4147 or 412-624-0409
Website: http://www.umc.pitt.edu/
280 articles with University of Pittsburgh
-
Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program
1/31/2023
Coeptis Therapeutics Holdings, Inc. today announced a sponsored research agreement with the University of Pittsburgh to advance pre-clinical development of SNAP-CAR T cells targeting HER2 as well as identify opportunities to expand the applicability of SNAP-CAR in oncology.
-
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh
1/5/2023
Genprex, Inc. announced it has entered into an exclusive license agreement with the University of Pittsburgh, granting Genprex a worldwide, exclusive license to a patent application and related technology and a worldwide, non-exclusive license to use certain related know-how, all related to gene therapy for Type 2 diabetes using the genes of the Pdx1 and MafA transcription factors.
-
Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh
12/15/2022
Genprex, Inc. today announced it has entered into an exclusive license agreement (the Agreement) with the University of Pittsburgh, granting Genprex a worldwide, exclusive license to certain patent applications and related technology and a worldwide, non-exclusive license to use certain related know-how, all related to modulating autoimmunity in Type 1 diabetes by using gene therapy.
-
Synchron to Begin Patient Enrollment for the COMMAND Trial of a Brain Computer Interface at University of Pittsburgh
10/27/2022
Synchron announced enrollment in the COMMAND trial has commenced at the University of Pittsburgh, Pittsburgh, PA.
-
Coeptis Therapeutics Enters Exclusive License Agreement with University of Pittsburgh for Rights to SNAP-CAR
9/21/2022
Coeptis Therapeutics, Inc. today announced entry into an exclusive license agreement with the University of Pittsburgh for the rights to a chimeric antigen receptor T cell (CAR T) technology – SNAP-CAR – designed to target multiple antigens simultaneously and potentially address a range of hematologic and solid tumors, including breast and ovarian cancer.
-
Covid-19, aging, stroke, ALS, colorectal cancers and Alzheimer's disease are all the focus of this week's top research stories.
-
Key findings identify the mechanism behind how senescent cells become zombified, migraine drugs could combat obesity and new AI may identify vaccine hesitancy.
-
Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors
5/17/2022
Coeptis Therapeutics, Inc. today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors.
-
The Richard King Mellon Foundation has awarded a $100 million gift to the University of Pittsburgh and approved a $150 million grant for Carnegie Mellon University.
-
BridgeBio Pharma Announces Collaborations with Three Academic Research Institutions
7/8/2021
BridgeBio Pharma, Inc. today announced three new academic collaborations with MUSC Foundation for Research Development, Stanford University and the University of Pittsburgh (Pitt) to translate cutting-edge discoveries into potential therapies for patients with genetic diseases and genetically driven cancers.
-
Kezar Life Sciences Announces Formation of Clinical Advisory Committee
6/8/2021
Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, announced the formation of its Clinical Advisory Committee.
-
Pitt's Plans for Growth of Regional Life Sciences Cluster Get Boost From $25 Million Gift; Advancements in Vision Care Lead the Way
2/25/2021
Philadelphia has its pharmaceutical cluster, San Francisco is known for its tech startups, and Boston boasts about its investment capital.
-
Clinical Catch-Up: September 7-11
9/14/2020
It was a busy week for clinical trial updates. Here’s a look. -
It’s likely that more companies and universities will add additional assets as time goes on.
-
Almost 15,000 physicians, scientists, health care professionals and industry representatives from around the globe presented research, treatment recommendations and advances toward a diabetes cure at the American Diabetes Association's 79th Scientific Sessions in San Francisco this week.
-
Verily announced a strategic collaboration deal with Novartis, Otsuka, Pfizer, Sanofi and six major health systems.
-
A bacteriophage is a virus that infects bacteria. They aren’t typically used to treat bacterial infections, but in desperate cases, they have been used to treat particularly antibiotic-resistant infections.
-
Today has been marked by a wide range of life science and biopharma stories. Here’s a broader look at some of the top stories.
-
Research Roundup: Gene Therapy for Deafness, Autism Genes, Breakthroughs in Parkinson’s and ALS, ...
3/1/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
The U.S. Senate Finance Committee and the House Oversight Committee started hearings on Tuesday, January 29, focused on dealing with high drug prices.